[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:human-papillomavirus-infection":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":265,"states":274},"Human Papillomavirus Infection",42,30,[8,16,22,28,34,40,46,52,58,64,70,76,82,88,94,100,106,112,118,124,130,136,142,148,154,160,166,171,177,183,189,197,203,209,215,221,227,234,240,246,251,258],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06210854","Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16\u002F18+",[12],"Phase 2","RECRUITING","2026-08-26T02:19:29.922117Z","2026-07-05T05:32:16.748142Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07601074","A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)",[12],"2026-08-26T02:15:34.659160Z","2026-06-04T01:30:07.904084Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT04098744","Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2\u002F3)",[12],"2026-08-26T02:15:10.362237Z","2026-05-05T02:43:26.716941Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT07164391","Empowering Vietnamese Americans",[],"2026-08-26T02:17:55.355429Z","2026-05-29T15:36:40.180279Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT05984849","Playing Game to Learn About Children's Vaccine Project",[],"2026-08-26T02:16:52.995882Z","2026-05-05T02:43:28.846489Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT07281430","Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)",[],"2026-08-26T02:17:54.420226Z","2026-05-05T02:43:28.709835Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":50,"content_modified":51},"NCT06598475","Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino\u002Fa Adolescents",[],"2026-08-26T02:17:57.997171Z","2026-05-05T02:43:28.639266Z",{"nct_id":53,"title":54,"phases":55,"status":13,"updated_at":14,"content_modified":57},"NCT05672927","Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)",[56],"Phase 4","2026-05-05T02:43:28.557738Z",{"nct_id":59,"title":60,"phases":61,"status":13,"updated_at":62,"content_modified":63},"NCT06831929","HPV Ends Here: Increasing Uptake of the HPV Vaccine",[],"2026-08-26T02:16:54.876240Z","2026-05-05T02:43:28.302787Z",{"nct_id":65,"title":66,"phases":67,"status":13,"updated_at":68,"content_modified":69},"NCT04611022","Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine",[],"2026-08-26T02:18:01.700186Z","2026-05-05T02:43:28.298253Z",{"nct_id":71,"title":72,"phases":73,"status":13,"updated_at":74,"content_modified":75},"NCT06535139","ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention",[],"2026-08-26T02:18:51.833592Z","2026-05-05T02:43:27.430229Z",{"nct_id":77,"title":78,"phases":79,"status":13,"updated_at":80,"content_modified":81},"NCT05266898","Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV",[56],"2026-08-26T02:15:56.561131Z","2026-05-05T02:43:27.288733Z",{"nct_id":83,"title":84,"phases":85,"status":13,"updated_at":86,"content_modified":87},"NCT06587243","\"Facts Tell… and With Stories Sell?\" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake",[],"2026-08-03T02:06:20.225302Z","2026-05-05T02:43:27.061640Z",{"nct_id":89,"title":90,"phases":91,"status":13,"updated_at":92,"content_modified":93},"NCT06624839","Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV",[12],"2026-08-26T02:19:21.761002Z","2026-04-29T02:57:57.072987Z",{"nct_id":95,"title":96,"phases":97,"status":13,"updated_at":98,"content_modified":99},"NCT06416150","Reducing Urban Cervical Cancer Disparities",[],"2026-08-26T02:15:28.524219Z","2026-05-05T02:43:27.483549Z",{"nct_id":101,"title":102,"phases":103,"status":13,"updated_at":104,"content_modified":105},"NCT06825689","Unidos Contra el VPH",[],"2026-08-26T02:17:50.500039Z","2026-05-05T02:43:27.273477Z",{"nct_id":107,"title":108,"phases":109,"status":13,"updated_at":110,"content_modified":111},"NCT07281599","Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer",[],"2026-08-26T02:17:45.190188Z","2026-05-05T02:43:27.262267Z",{"nct_id":113,"title":114,"phases":115,"status":13,"updated_at":116,"content_modified":117},"NCT05372484","Rice Technologies for Cervical Cancer Screening and Diagnosis",[],"2026-08-26T02:16:38.897933Z","2026-05-05T02:43:27.060298Z",{"nct_id":119,"title":120,"phases":121,"status":13,"updated_at":122,"content_modified":123},"NCT07232355","Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling",[],"2026-08-26T02:15:44.309045Z","2026-05-13T02:55:06.679945Z",{"nct_id":125,"title":126,"phases":127,"status":13,"updated_at":128,"content_modified":129},"NCT06434337","Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)",[],"2026-08-26T02:16:39.977107Z","2026-05-13T02:55:06.491362Z",{"nct_id":131,"title":132,"phases":133,"status":13,"updated_at":134,"content_modified":135},"NCT05026138","Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)",[],"2026-08-26T02:18:02.701182Z","2026-05-13T02:55:06.279881Z",{"nct_id":137,"title":138,"phases":139,"status":13,"updated_at":140,"content_modified":141},"NCT07087145","Feasibility of HPV Testing With Mail-delivered Sample Collection Kits",[],"2026-08-26T02:19:23.493898Z","2026-05-13T02:55:06.651306Z",{"nct_id":143,"title":144,"phases":145,"status":13,"updated_at":146,"content_modified":147},"NCT01905826","Natural History Study of GATA2 Deficiency and Related Disorders",[],"2026-08-26T02:16:48.735701Z","2026-05-13T02:55:06.080103Z",{"nct_id":149,"title":150,"phases":151,"status":13,"updated_at":152,"content_modified":153},"NCT00006518","Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer",[],"2026-08-26T02:17:21.315591Z","2026-05-13T02:55:06.028653Z",{"nct_id":155,"title":156,"phases":157,"status":13,"updated_at":158,"content_modified":159},"NCT07336134","PopSci CHW4CervixHealth",[],"2026-08-26T02:16:47.762107Z","2026-05-05T02:43:29.507866Z",{"nct_id":161,"title":162,"phases":163,"status":13,"updated_at":164,"content_modified":165},"NCT06799494","HPV Vaccine Reduced Dose",[56],"2026-08-26T02:15:03.757872Z","2026-05-05T02:43:29.360661Z",{"nct_id":167,"title":168,"phases":169,"status":13,"updated_at":44,"content_modified":170},"NCT07301905","Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI",[],"2026-05-05T02:43:29.039143Z",{"nct_id":172,"title":173,"phases":174,"status":13,"updated_at":175,"content_modified":176},"NCT05336240","PCOM2 - The Physician Communication Intervention, Version 2.0",[],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:28.177777Z",{"nct_id":178,"title":179,"phases":180,"status":13,"updated_at":181,"content_modified":182},"NCT05365048","Provider Recommendation and HPV Vaccination",[],"2026-08-26T02:18:18.766496Z","2026-05-05T02:43:27.168927Z",{"nct_id":184,"title":185,"phases":186,"status":13,"updated_at":187,"content_modified":188},"NCT06380114","Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination",[],"2026-08-26T02:19:00.742020Z","2026-05-05T02:43:26.672559Z",{"nct_id":190,"title":191,"phases":192,"status":194,"updated_at":195,"content_modified":196},"NCT06233331","Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV",[193],"Phase 1","NOT_YET_RECRUITING","2026-08-26T02:16:11.347936Z","2026-05-05T02:43:27.099698Z",{"nct_id":198,"title":199,"phases":200,"status":194,"updated_at":201,"content_modified":202},"NCT07090174","Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV",[12],"2026-08-03T03:11:37.958805Z","2026-05-05T02:43:27.828081Z",{"nct_id":204,"title":205,"phases":206,"status":194,"updated_at":207,"content_modified":208},"NCT07657104","Developing and Implementing HPV SCREENED",[],"2026-08-26T02:15:14.574786Z","2026-06-18T12:24:03.101479Z",{"nct_id":210,"title":211,"phases":212,"status":194,"updated_at":213,"content_modified":214},"NCT07733557","HPV Detection Using Self-Collected Menstrual Blood",[],"2026-08-26T02:17:11.311767Z","2026-07-30T01:46:14.455023Z",{"nct_id":216,"title":217,"phases":218,"status":194,"updated_at":219,"content_modified":220},"NCT07520188","C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States",[],"2026-08-26T02:16:00.194860Z","2026-07-05T05:32:16.684811Z",{"nct_id":222,"title":223,"phases":224,"status":194,"updated_at":225,"content_modified":226},"NCT03429413","Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial",[],"2026-08-26T02:18:24.494016Z","2026-05-05T02:43:29.323842Z",{"nct_id":228,"title":229,"phases":230,"status":231,"updated_at":232,"content_modified":233},"NCT07412743","Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:05.813655Z","2026-06-16T05:54:07.883041Z",{"nct_id":235,"title":236,"phases":237,"status":231,"updated_at":238,"content_modified":239},"NCT06508138","Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig\u002FE7(Detox)\u002FHSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection",[193],"2026-08-26T02:18:31.944757Z","2026-06-16T05:54:07.758870Z",{"nct_id":241,"title":242,"phases":243,"status":231,"updated_at":244,"content_modified":245},"NCT06144229","Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies",[],"2026-08-26T02:18:15.214990Z","2026-06-16T05:54:08.099637Z",{"nct_id":247,"title":248,"phases":249,"status":231,"updated_at":50,"content_modified":250},"NCT05524480","Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention",[],"2026-06-16T05:54:08.036225Z",{"nct_id":252,"title":253,"phases":254,"status":255,"updated_at":256,"content_modified":257},"NCT05065840","Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:05.931134Z","2026-04-29T02:57:57.117979Z",{"nct_id":259,"title":260,"phases":261,"status":262,"updated_at":263,"content_modified":264},"NCT05860725","Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy",[],"UNKNOWN","2026-08-03T02:26:49.291027Z","2026-05-05T02:35:31.864198Z",[266,270],{"biomarker":267,"count":268,"slug":269},"HPV",8,"hpv",{"biomarker":271,"count":272,"slug":273},"HIV Infection",5,"hiv-infection",[275,279,283,286,289,293,296,300,303,306,309],{"state":276,"count":277,"slug":278},"Texas",9,"texas",{"state":280,"count":281,"slug":282},"Maryland",7,"maryland",{"state":284,"count":272,"slug":285},"Georgia","georgia",{"state":287,"count":272,"slug":288},"New York","new-york",{"state":290,"count":291,"slug":292},"California",4,"california",{"state":294,"count":291,"slug":295},"Florida","florida",{"state":297,"count":298,"slug":299},"Colorado",3,"colorado",{"state":301,"count":298,"slug":302},"Louisiana","louisiana",{"state":304,"count":298,"slug":305},"Michigan","michigan",{"state":307,"count":298,"slug":308},"Ohio","ohio",{"state":310,"count":298,"slug":311},"Pennsylvania","pennsylvania"]